Evidence map›Paper›PMID 39607658›Full record

ArticleInternational journal of clinical pharmacy2025

Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study.

Widya N Insani, Li Wei, Rizky Abdulah, Sofa D Alfian, Nurul A Ramadhani, Rizky Andhika, Neily Zakiyah, Matthew Adesuyan, Yunisa Pamela, Rima Mustafa and 1 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of clinical pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Widya N InsaniDepartment of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.ORCID http://orcid.org/0000-0002-0066-9746
Li WeiResearch Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
Rizky AbdulahDepartment of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.
Sofa D AlfianDepartment of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.
Nurul A RamadhaniDepartment of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.
Rizky AndhikaDivision of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Padjadjaran University, Hasan Sadikin General Hospital, Bandung, Indonesia.
Neily ZakiyahDepartment of Pharmacology and Clinical Pharmacy, Padjadjaran University, Bandung, Indonesia.
Matthew AdesuyanResearch Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
Yunisa PamelaDepartment of Biomedical Sciences, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia.
Rima MustafaDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Cate WhittleseaResearch Department of Practice and Policy, School of Pharmacy, University College London, London, UK. c.whittlesea@ucl.ac.uk.ORCID http://orcid.org/0000-0002-4951-2272

Funding

Lembaga Pengelola Dana Pendidikan 201908223215121
6 · The paper itself

Abstract

backgroundEffective hypertension management requires medication adherence to prevent complications. However, adverse drug reactions (ADRs) can undermine adherence and negatively affect patients' quality of life. Limited research has explored the association between ADRs, medication adherence, and health-related quality of life (HRQoL) in individuals with hypertension.

aimTo investigate the association between ADRs, medication adherence, and HRQoL among patients with hypertension.

methodA cross-sectional study using telephone interviews and medical record reviews was conducted in 11 primary care facilities in Indonesia. The causality of reported ADRs was assessed using the Naranjo algorithm, validated by a panel of experts in pharmacy practice and medication safety. The severity of ADRs was classified using the Hartwig scale. Adherence to antihypertensive drugs was estimated using the Medication Adherence Report Scale-5 (MARS-5). The EuroQoL EQ-5D-5L was used to measure HRQoL. The association between ADRs and medication adherence was assessed using multivariate logistic regression, while the association with HRQoL was evaluated through the Tobit regression model.

resultsA total of 507 patients were included in this study. We found that 20.32% (n = 103) of the patients experienced ADRs, with the most commonly reported ADRs being polyuria and urgency, gastrointestinal symptoms, leg swelling, dizziness/hypotension, palpitations, and dry cough. The majority experienced mild ADRs (n = 75, 72.82%), while 27.18% (n = 28) had reactions of moderate severity. Experiencing ADRs was associated with reduced medication adherence (adjusted odds ratio (OR) 7.15, 95% CI 4.07-12.55) and decreased HRQoL (coefficient: - 0.037).

conclusionPatients experiencing ADRs were seven times more likely to be non-adherent to their medication regimen and reported a reduced quality of life compared to those without ADRs, placing them at a higher risk of suboptimal treatment outcomes. This finding highlights the need for additional monitoring and education for patients affected by ADRs, particularly through more frequent clinical and laboratory assessments, timely management of ADRs, and personalized education on the importance of adherence to prevent hypertension-related complications.

Indexed as

Antihypertensive AgentsDrug-Related Side Effects and Adverse ReactionsHypertensionMedication AdherenceQuality of LifeAdultAgedCross-Sectional StudiesFemaleHumansIndonesiaMaleMiddle AgedAntihypertensive AgentsAdverse drug reactionsHypertensionMedication adherenceQuality of life

Identifiers

PMID39607658
PMCPMC11919996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.